Sono-Tek Corp (SOTK) - Fiscal 2025 10-K Summary
Business Context and Reporting Period
Company: Sono-Tek Corp (SOTK)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year ended February 28, 2025 (Fiscal 2025)
Business Overview: Sono-Tek is the world leader in designing and manufacturing ultrasonic coating systems for microelectronics, alternative energy, medical, and industrial markets. The company utilizes patented ultrasonic nozzle technology to apply precise, thin-film coatings to surfaces. Operations are centralized in Milton, New York, with sales and service offices globally.
Key Financial Metrics
| Metric | Fiscal 2025 | Fiscal 2024 | Change |
|---|---|---|---|
| Net Sales | $20.50 million | $19.70 million | +4.1% |
| Gross Profit | $9.74 million | $9.84 million | -1.1% |
| Gross Margin | 47.5% | 50.0% | -250 bps |
| Operating Income | $1.01 million | $1.18 million | -14.6% |
| Net Income | $1.27 million | $1.44 million | -11.7% |
| Diluted EPS | $0.08 | $0.09 | -11.1% |
| Backlog | $8.68 million | $9.28 million | -6.6% |
| Cash & Equivalents | $5.20 million | $2.13 million | +144% |
| Total Cash & Securities | $11.93 million | $11.85 million | +0.7% |
| Debt | $0 | $0 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Record annual revenue of $20.5 million was achieved, driven primarily by a 64% surge in the Alternative/Clean Energy market ($9.84 million), fueled by production-scale system shipments to solar and electrolysis sectors.
- Margin Compression: Gross margin declined to 47.5% from 50.0%. Management attributed this to product mix shifts and the reclassification of specific engineering labor costs from R&D to Cost of Goods Sold (COGS).
- Market Divergence: While Clean Energy sales soared, the Industrial market declined 47% due to reduced demand for float glass coating systems amid competition from China. Medical sales also dropped 22%.
- Geographic Shift: US and Canada sales increased 15% to $12.5 million, representing 61% of total sales, offsetting declines in Latin America (-34%) and Asia Pacific (-16%).
- Operating Expenses: Total operating expenses rose slightly by 1% to $8.73 million. General and Administrative (G&A) costs increased 12% due to salary reclassifications (CEO compensation moved from Sales to G&A) and professional fees, partially offset by a $66,000 reversal of a sales tax accrual.
Guidance, Outlook, and Risks
Outlook & Strategy: Management continues to focus on transitioning from selling components to providing complete, high-value equipment solutions. The company is aggressively pursuing growth in the clean energy sector and expanding its global footprint. No specific numerical guidance for Fiscal 2026 was provided in this filing.
Key Risks & Contingencies:
- Customer Concentration: One customer accounted for 11% of net sales in Fiscal 2025. The company relies on a limited number of major customers and distributors.
- Supply Chain & Raw Materials: The company faces risks related to the availability and pricing of electronic components and raw materials, though it has not historically been severely impacted.
- Trade Policy: International sales (39% of total) expose the company to tariffs, trade restrictions, and geopolitical instability.
- Single Facility Risk: All manufacturing and assembly occur at one facility in Milton, NY. A prolonged disruption would materially impact operations.
- Intellectual Property: The business relies heavily on patents and trade secrets; litigation or infringement could be costly.
Investor Verification Checklist
- Margin Sustainability: Verify if the reclassification of labor costs to COGS is a one-time adjustment or a permanent structural change affecting future margins.
- Clean Energy Dependency: Assess the sustainability of the 64% growth in the Alternative Energy sector and the impact of potential changes to US government clean energy incentives (e.g., Inflation Reduction Act).
- Backlog Conversion: Monitor the conversion rate of the $8.68 million backlog into revenue, noting the 6.6% year-over-year decline in backlog levels.
- Customer Concentration: Review the identity and financial health of the customer representing 11% of sales to assess concentration risk.
- Stock Repurchase Program: Track the execution of the $2 million stock repurchase plan authorized in late 2024; only 2,116 shares were purchased in Q4 FY2025.